SCHEMBL424499

SCHEMBL424499

CCCCCCCC/C=C\CCCCCCCC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.76
CNR1 P21554 3/20 0.69
SLC6A5 Q9Y345 3/20 0.61
PSMB11 A5LHX3 2/20 0.59
PSMA7 O14818 2/20 0.59
PSMB1 P20618 2/20 0.59
PSMA1 P25786 2/20 0.59
PSMA2 P25787 2/20 0.59
PSMA3 P25788 2/20 0.59
PSMA4 P25789 2/20 0.59
PSMB8 P28062 2/20 0.59
PSMB9 P28065 2/20 0.59
PSMA5 P28066 2/20 0.59
PSMB4 P28070 2/20 0.59
PSMB6 P28072 2/20 0.59
PSMB5 P28074 2/20 0.59
PSMB10 P40306 2/20 0.59
PSMB3 P49720 2/20 0.59
PSMB2 P49721 2/20 0.59
PSMA6 P60900 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL424501 1.00 FAAH (0.76) FAAHCNR1SLC6A5PSMB11PSMA7
SCHEMBL424500 1.00 FAAH (0.76) FAAHCNR1SLC6A5PSMB11PSMA7
SCHEMBL31026947 1.00 FAAH (0.76) FAAHCNR1SLC6A5PSMB11PSMA7
SCHEMBL9954851 1.00 FAAH (0.76) FAAHCNR1SLC6A5PSMB11PSMA7
SCHEMBL15649626 1.00 FAAH (0.76) FAAHCNR1SLC6A5PSMB11PSMA7
SCHEMBL28342298 0.98 CNR1 (0.73) FAAHCNR1SLC6A5PSMB11PSMA7
SCHEMBL15285295 0.98 CNR1 (0.73) FAAHCNR1SLC6A5PSMB11PSMA7
SCHEMBL16620402 0.98 FAAH (0.72) FAAHCNR1SLC6A5PSMB11PSMA7
SCHEMBL16620399 0.98 FAAH (0.72) FAAHCNR1SLC6A5PSMB11PSMA7
SCHEMBL29813833 0.94 CNR1 (0.68) FAAHCNR1SLC6A5PSMB11PSMA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122005359-A Hair dye integrating dyeing and protecting functions and preparation method thereof 广州市圣莎拉化妆品有限公司 2026-05-12 CN claimed
EP-3322488-B1 COSMETIC COMPOSITION BAKEL S R L (IT) 2022-11-30 EP claimed
US-11013681-B2 Cosmetic composition BAKEL SRL (IT) 2021-05-25 US claimed
CN-111514056-A Polypeptide composition with melanin generation promoting effect and application thereof 深圳市维琪医药研发有限公司 2020-08-11 CN claimed
US-20180207085-A1 COSMETIC COMPOSITION BAKEL SRL (IT) 2018-07-26 US claimed
EP-3322488-A1 COSMETIC COMPOSITION Bakel S.R.L. (IT) 2018-05-23 EP claimed
WO-2016178179-A1 COMPOSITION FOR SUN PROTECTION CLAIRE S.P.A. (IT) 2016-11-10 WO claimed
US-20150086694-A1 N-Acyl-Amino Acid Derivatives for Improvement of the Flavour Profile Edible Compositions GIVAUDAN SA (CH) 2015-03-26 US claimed
US-20150072060-A1 Organic Compounds GIVAUDAN SA (CH) 2015-03-12 US claimed
US-20150050408-A1 Powder Flavour Composition GIVAUDAN SA (CH) 2015-02-19 US claimed
EP-2830439-A2 N-ACYL-AMINO ACID DERIVATIVES FOR IMPROVEMENT OF THE FLAVOUR PROFILE EDIBLE COMPOSITIONS Givaudan SA (CH) 2015-02-04 EP claimed
EP-2830438-A2 N-ACYL-AMINO ACID DERIVATIVES AS FOOD FLAVOURING COMPOUNDS, POWDER COMPOSITIONS CONTAINING THEM Givaudan SA (CH) 2015-02-04 EP claimed
WO-2013149035-A2 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN S.A. (CH) 2013-10-03 WO claimed
WO-2013149031-A2 POWDER FLAVOUR COMPOSITION GIVAUDAN S.A. (CH) 2013-10-03 WO claimed
EP-4626396-B1 A PERSONAL CARE COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2026-05-20 EP disclosed
CN-122005359-A Hair dye integrating dyeing and protecting functions and preparation method thereof 广州市圣莎拉化妆品有限公司 2026-05-12 CN disclosed
CN-121868163-A Anti-wrinkle moisturizing cream containing vitronectin and preparation method thereof 广东尚品汇化妆品股份有限公司 2026-04-17 CN disclosed
EP-2120846-A2 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS BASF SE (DE) 2009-11-25 EP disclosed
WO-2008107347-A2 USE OF AMINES AND AMIDES FOR THE STABILIZATION OF ORGANIC MICRONIZED UV ABSORBERS BASF SE (CH) 2008-09-12 WO disclosed
EP-1818060-A1 Cosmetic composition comprising Fadogia ancylantha extracts ARTSANA S.p.A. (IT) 2007-08-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150072060-A1 Organic Compounds GABRB3, GABRB2, GABRB1 FAAH 1419/4885CNR1 286/4885SLC6A5 2041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.